Melatonin as an adjuvant therapy in gestational hypertension and pre-eclampsia: A randomized controlled trial
In spite of the improvement of obstetric care, hypertensive disorders of pregnancy have continued to emerge as the major causes of maternal and perinatal morbidity. Therefore, it is of interest to assess the effectiveness of melatonin as an adjuvant treatment in the management of gestational hypertension and pre-eclampsia in 404 pregnant women (183 taking melatonin